Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Companies
Aceto Corporation Aceto Corporation (Aceto) is a marketer and distributor of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals. The company’s business is organized into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It distributes more than 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. Geographically, the company has a presence in nine countries, namely, China, France, Germany, the Netherlands, India, Hong Kong, Singapore, the UK and the US. Aceto is headquartered in Port Washington, New York, the US. The business strategy of the company focuses on sourcing and qualifying pharmaceutical intermediates and active ingredients, nutraceutical products, finished dosage form generics, specialty chemicals and agricultural protection products from manufacturers globally. It also aims to provide high quality regulatory support and quality assurance services to its customers and suppliers worldwide. It aims to globalize and expand its nutraceutical packaged dietary supplements business with focus on growth markets to increase the offerings of finished dosage form generic branded products. Company Data STAAR Surgical Company STAAR Surgical Company (STAAR) is a medical device company. The company designs, develops, manufactures and markets implantable lenses for the eye and delivery systems. Its products include refractive and cataract solutions. STAAR offers refractive solutions such as Visian ICL with CentraFLOW, Visian ICL and Visian Toric ICL. The company’s cataract solutions include toric, acrylic, silicone and collamer IOLs. Its products are used to treat patients with Myopia disease. The company markets products under brand names, Collamer, Visian ICL and STAAR. It has manufacturing and administrative facilities in the US, Switzerland, Spain and Japan. STAAR is headquartered in Monrovia, California, the US. Company Data DiaGenic ASA DiaGenic ASA (DiaGenic) is an innovative diagnostic company. It undertakes the development of novel and patient-friendly in vitro diagnostics (IVD) for early detection of diseases. The company specializes in developing blood-based biomarkers for early detection of Alzheimer’s disease (AD). Its gene signatures have diverse applications in the diagnostic work related to AD. The company’s lead product, ADtect is a blood test that helps distinguish mild to moderate AD from the absence of dementia. The company operates through a single business segment that undertakes the research and development of blood-based gene expression tests within the AD area. The company is also developing three AD diagnostic tests, which are in pipeline. DiaGenic is headquartered in Oslo, Norway. Company Data Sartorius AG Sartorius AG (Sartorius) is a Germany-based laboratory and process technology and equipment provider. The company undertakes the manufacture and distribution of laboratory and process technology equipment. It sells its products to the companies in the pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and abroad. The company has production facilities in Europe, Asia and America. It provides its products across the world through a network of sales subsidiaries and local commercial agencies. It operates in Germany and conducts operations in Europe, Asia-Pacific and North America and Rest of the World through its subsidiaries. Sartorius is headquartered in Goettingen, Germany. Company Data Waters Corporation Waters Corporation (Waters) is a US-based analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, rheometry and calorimetry instruments. The company operates in two divisions, namely, Waters Division that supports liquid chromatography and mass spectrometry technologies, and TA Instruments division that supports thermal analysis technologies. The company’s products are widely utilized by pharmaceutical, biochemical, life sciences, industrial, academic and government customers working in research and development, quality assurance and other laboratory applications. Waters is headquartered in Milford, Massachusetts, the US. Company Data Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical Co., Ltd. (Daewoong Pharma) is pharmaceutical company. It is one of the leading manufacturers and distributors of prescription drugs in Korea. The company offers product in the forms of tablets, capsules, ointments, injections, liquids and sprays. Daewoong Pharma offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular treatments, central nervous system treatments, circulatory system agents, dermatologic agents, gastrointestinal agents, health supplements, respiratory remedies and others. It also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. The company has presence in major Asian markets including Indonesia, China, Vietnam, Thailand and India. It operates with fourteen branches in Korea, seven in Asia and one in the US. Daewoong Pharma is headquartered in Seoul, Republic of Korea. Company Data Lumara Health Inc. Lumara Health Inc. (Lumara), formerly K-V Pharmaceutical Company, is a specialty pharmaceutical company. It develops and commercializes branded pharmaceuticals in various dosage forms such as solids, semi-solids and liquids. The company focuses its products in the women healthcare area. It operates through two business divisions, namely, Maternal Health and Women’s Healthcare. Maternal Health Division focuses on addressing preterm birth and Women’s Healthcare Division focuses on women’s health with products for menopausal symptoms and vaginal infections. The product portfolio of the company includes anti-infectives and estrogen therapy products that are marketed under Evamist, Clindesse, Gynazole-1 and Makena brands. The company markets its products through its subsidiary Ther-Rx Corporation. Lumara is headquartered in Missouri, the US. Company Data Ebro Foods SA Ebro Foods, S.A. (Ebro) is a food processing company in Spain. The company is specialized in production and distribution of rice, pasta and sauces. The company’s product portfolio includes a wide range of rice such as organic rice, Italian Arborio, Indian basmati, Thai jasmine and wild rice blends; ready to serve rice; pastas; convenience foods; and sauces. Ebro markets its products under various brands including SOS, Brillante, La Fallera, American Rice, Gourmet House, La Cigala, Rocio, Lustucru, Taureau Aile, Birkel, Regia, Ferrero and 3Glocken among others. The company operates through more than 20 subsidiaries in 25 countries across Africa, North America, Europe and Asia. Ebro is headquartered in Madrid, Spain. Company Data BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company. The company develops and commercializes products in the areas of pain management and oncology supportive care, including chronic pain, breakthrough cancer pain, opioid dependence, and nausea and vomiting related cancer pain. BDSI's patented drug delivery technologies include: BioErodible MucoAdhesive (BEMA) technology, which consists of a small dissolvable polymer film for application to mucosal membranes for transmucosal delivery of drugs for time critical conditions and Bioral technology, which is based upon a novel process of encapsulating or protecting a drug to facilitate oral dosing of drugs otherwise given by intravenous administration. Its pipeline candidates include BEMA Buprenorphine, BEMA Granisetron and BEMA Buprenorphine/Naloxone. BDSI is headquartered in Raleigh, North Carolina, the US. Company Data JSC Farmak International JSC Farmak International (Farmak) is a drug manufacturing company. It undertakes the manufacturing and marketing of finished medicines and pharmaceutical substances to the healthcare markets. The company’s product portfolio includes Lamicon dermgel, Arfa Combi, Avouge Plus, Antral, Benzylbenzoate , Ciprofarm and Dioxydine, among others. It offers therapeutic products in the areas of endocrinology, anti-allergy, neurology, cardiology, ophthalmology, gastroenterolog, diagnostics, dermatology, gynecology and others. Farmak offers services, such as production of pharmaceuticals for human medicine, contract manufacturing, scientific research and pharmaceutical substances synthesis. The company operates through its representative offices in Kazakhstan, Uzbekistan, Russian Federation and Kyrgyz Republic. Farmak is headquartered in Kyiv, Kiev, Ukraine. Company Data Helix BioMedix, Inc. Helix BioMedix, Inc. (Helix) is a biopharmaceutical company. It develops diverse proprietary bioactive peptides. It carries out peptide design, synthesis and characterization followed by assay development, screening, tissue culture and microbiology. The company’s pipeline products include anti-infective HB1345, HB1275 topical anti-fungal and other drug candidates for dermatological conditions. The company develops peptides for the consumer skin care products and prescription products. The peptides developed by the company are used in various applications including, anti-aging skin care, acne treatment, wound healing and other topical anti-infective treatments. Helix leverages these bioactive peptides by partnering with contract research organizations and peptide manufacturers. Helix markets its products under the brand names, Apothederm and SmartPeptide. Helix is headquartered in Bothell, Washington, the US. The company seeks to develop new proprietary technologies in anti-infectives, dermatology personal care and cosmeceuticals; and derive revenues from licensing its technologies to third parties. Company Data AorTech International plc AorTech International plc (AorTech) is a medical device company. It undertakes development, manufacture, and commercialization of biomedical polymer technology, components and medical devices. The company provides a broad range of polyurethane materials for applications in cardiovascular surgery, interventional cardiology, cardiac rhythm management, orthopedic, plastic surgery, gastroenterological and urological applications. It offers Elast-Eon biostable polyurethanes used in medical devices for long term implantation; ECSil, biomedical polymers for pacing and neurostimulation leads, spinal disc, and breast implant; and Elast-Eon reaction injection molding (RIM) products. AorTech is headquartered in Surrey, Scotland, the UK. AorTech focuses on the development and protection of its product portfolio through patents and licensing of its products and proprietary technology. The company also focuses on development of a wide span of pipeline products for its medical devices business. Company Data Akorn, Inc. Akorn, Inc. (Akorn) is a niche generic pharmaceutical company. The company carries out the development, manufacturing and commercialization of diagnostic and therapeutic ophthalmic pharmaceuticals; and hospital drugs and injectables. The company's product offer treatment in ophthalmology, antidotes, anti-infectives, pain management, anesthesia, vaccines and others. It also offers contract manufacturing services. Akorn offers these products and services to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. It operates manufacturing facilities in India and the US. Along with its subsidiaries, the company operates in the US, Mauritius and India. Akorn is headquartered in Lake Forest, Illinois, the US. Company Data Karo Bio AB Karo Bio AB (Karo Bio) is a pharmaceutical company .The company focuses on development and innovation of drugs. The key research area of the company involves nuclear receptors. The company is actively involved in preclinical development in the fields of neuropsychiatry, inflammation, autoimmune diseases and cancer. It is currently involved in projects based on ROR gamma receptor and estrogen receptor (ER). The studies based on ER beta explore its potential in the treatment of cancer and MS whereas, the study on ROR receptor is being conducted in collaboration with Pfizer, the study investigates the role of ROR gamma in the development of autoimmune diseases such as rheumatoid arthritis and psoriasis. Karo Bio is headquartered in Huddinge, Sweden. Company Data Meiji Holdings Co., Ltd. Meiji Holdings Co., Ltd. (Meiji Holdings) is a conglomerate operating in dairy products, confectionery and healthcare and pharmaceutical industries. It focuses on the manufacture and selling of fresh dairy products, powdered milk, condensed milk, butter, cheese, confectioneries, sugar, corn sweeteners, functional healthcare products, ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company also provides transportation, storage and mechanical engineering services, among others. Meiji Holdings principally operates through its two subsidiaries, namely, Meiji Co, Ltd., and Meiji Seika Pharma Co., Ltd. The company has presence in the US, China, India, Australia, Indonesia, Europe, Singapore and Thailand. Meiji Holdings is headquartered in Tokyo, Japan. Company Data Taisho Pharmaceutical Co., Ltd. Taisho Pharmaceutical Co., Ltd. (Taisho) is a Japan-based pharmaceutical company. It carries out the development, manufacture and marketing of various pharmaceutical products. The company’s product portfolio includes a range of prescription pharmaceutical and self-medication (OTC) drugs. Some of its principal prescription pharmaceuticals include Palux injection, a peripheral vasodilator; Clarith, a macrolide antibiotic; Ancaron tablets for the treatment of cardiac arrhythmia; a nonsteroidal anti-inflammatory drug Lorcam tablets; and Solon, an anti-ulcer agent among others. Taisho is a leading company in the field of OTC medicines and markets a range of products on a global scale. Taisho is a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd. and is headquartered in Tokyo, Japan. Company Data Japan Tobacco Inc. Japan Tobacco Inc. (JT) is the world's third largest cigarette maker. It manufactures, distributes and sells tobacco products worldwide. The company’s internationally recognized cigarette brands include Camel, Mevius, Winston, and Benson & Hedges. It is also active in pharmaceutical and food businesses. The Pharmaceutical division of the company develops drugs for indications such as HIV infection, hepatitis C, dyslipidemia, hyperphosphatemia, type 2 diabetes mellitus, anemia and autoimmune/allergic diseases, while its Food division deals with processed foods, beverages and seasonings. The company has direct operations in more than 70 countries and its products are sold in more than 120 countries. JT is headquartered in Tokyo, Japan. Company Data Actavis plc Actavis plc (Actavis) (earlier known as Actavis, Inc.) is a specialty pharmaceutical company. It carries out the development, manufacturing, marketing and distribution of specialized branded and generic pharmaceutical and bio-similar products. After the Watson pharmaceuticals acquisition in November 2012, the company became the third-largest generic pharmaceutical company across the globe with operations in more than 60 countries. The products that the company offers are applied in the field of central nervous system, urology, women's health, hormones and synthetic substitutes, oncology, cardiovascular, nephrology and gastrointestinal amongst other therapeutic areas. By the end of fiscal 2012, Actavis markets more than 250 generic product and almost 40 branded products in the US as well as around the major pharmaceuticals markets. It business is majorly classified into three business segments, namely, Actavis Pharma, Actavis Specialty Brands and ANDA Distribution. In addition, the company develops and out-licenses generic pharmaceutical products through its Medis third-party business. Geographically, the company operates across the US in addition to key markets including Europe, Canada, Australia, Southeast Asia, South America and South Africa. The company distributes approximately 11,450 stock-keeping units (SKUs) through its ANDA Distribution business. Actavis is headquartered in Dublin, Ireland. Company Data Cortex Pharmaceuticals, Inc. Cortex Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of novel small molecule drugs called AMPAKINE molecules that target human central nervous system diseases. It is headquartered in Irvine, California, United States. Company Data ViroPharma Incorporated ViroPharma Incorporated (ViroPharma) is a biopharmaceutical company. It develops and commercializes products for the treatment of various serious life threatening ailments. The company’s marketed products include Cinryze, for the treatment of Hereditary Angioedema (HAE); Vancocin, for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus; Buccolam, for the treatment of Pediatric Epilepsy; and Plenadren for treatment of adrenal insufficiency in adults. The product pipeline of Viropharma comprises Cinryze (C1 esterase inhibitor [human]) for management of HEA; VP 20621 for the management of C. difficile infection (CDAD); and VP20629, for the treatment of Friedreich’s Ataxia. The company operates in the US, Belgium, France, Switzerland, Germany and the UK. ViroPharma is headquartered in Pennsylvania, the US. Company Data
121-140 of 1518 results

See all companies